vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Wheels Up Experience Inc. (UP). Click either name above to swap in a different company.
Wheels Up Experience Inc. is the larger business by last-quarter revenue ($183.8M vs $168.4M, roughly 1.1× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -10.2%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -3.4%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Wheels Up is a provider of "on demand" private aviation in the United States and one of the largest private aviation companies in the world. It was founded in 2013 by Kenny Dichter, using a membership/on-demand business model. Wheels Up members can book private aircraft from the company fleet and third-party operators using a mobile application.
ESPR vs UP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $183.8M |
| Net Profit | — | $-28.9M |
| Gross Margin | — | 14.3% |
| Operating Margin | 50.6% | -0.9% |
| Net Margin | — | -15.7% |
| Revenue YoY | 143.7% | -10.2% |
| Net Profit YoY | — | 67.0% |
| EPS (diluted) | $0.32 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $183.8M | ||
| Q3 25 | $87.3M | $185.5M | ||
| Q2 25 | $82.4M | $189.6M | ||
| Q1 25 | $65.0M | $177.5M | ||
| Q4 24 | $69.1M | $204.8M | ||
| Q3 24 | $51.6M | $193.9M | ||
| Q2 24 | $73.8M | $196.3M | ||
| Q1 24 | $137.7M | $197.1M |
| Q4 25 | — | $-28.9M | ||
| Q3 25 | $-31.3M | $-83.7M | ||
| Q2 25 | $-12.7M | $-82.3M | ||
| Q1 25 | $-40.5M | $-99.3M | ||
| Q4 24 | — | $-87.5M | ||
| Q3 24 | $-29.5M | $-57.7M | ||
| Q2 24 | $-61.9M | $-97.0M | ||
| Q1 24 | $61.0M | $-97.4M |
| Q4 25 | — | 14.3% | ||
| Q3 25 | — | 6.8% | ||
| Q2 25 | — | 8.3% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | — | 13.9% | ||
| Q3 24 | — | 13.9% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -0.6% |
| Q4 25 | 50.6% | -0.9% | ||
| Q3 25 | -11.4% | -33.1% | ||
| Q2 25 | 8.6% | -31.4% | ||
| Q1 25 | -34.0% | -45.5% | ||
| Q4 24 | -6.4% | -26.0% | ||
| Q3 24 | -31.0% | -21.6% | ||
| Q2 24 | 3.5% | -40.3% | ||
| Q1 24 | 52.5% | -42.9% |
| Q4 25 | — | -15.7% | ||
| Q3 25 | -35.9% | -45.1% | ||
| Q2 25 | -15.4% | -43.4% | ||
| Q1 25 | -62.2% | -55.9% | ||
| Q4 24 | — | -42.7% | ||
| Q3 24 | -57.2% | -29.8% | ||
| Q2 24 | -83.9% | -49.4% | ||
| Q1 24 | 44.3% | -49.4% |
| Q4 25 | $0.32 | $-0.04 | ||
| Q3 25 | $-0.16 | $-0.12 | ||
| Q2 25 | $-0.06 | $-0.12 | ||
| Q1 25 | $-0.21 | $-0.14 | ||
| Q4 24 | $-0.14 | $-0.13 | ||
| Q3 24 | $-0.15 | $-0.08 | ||
| Q2 24 | $-0.33 | $-0.14 | ||
| Q1 24 | $0.34 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $133.9M |
| Total DebtLower is stronger | — | $671.3M |
| Stockholders' EquityBook value | $-302.0M | $-392.1M |
| Total Assets | $465.9M | $968.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $133.9M | ||
| Q3 25 | $92.4M | $125.3M | ||
| Q2 25 | $86.1M | $107.0M | ||
| Q1 25 | $114.6M | $171.8M | ||
| Q4 24 | $144.8M | $216.4M | ||
| Q3 24 | $144.7M | $115.9M | ||
| Q2 24 | $189.3M | $141.5M | ||
| Q1 24 | $226.6M | $180.9M |
| Q4 25 | — | $671.3M | ||
| Q3 25 | — | $766.5M | ||
| Q2 25 | — | $770.5M | ||
| Q1 25 | — | $765.8M | ||
| Q4 24 | — | $761.3M | ||
| Q3 24 | — | $596.9M | ||
| Q2 24 | — | $597.4M | ||
| Q1 24 | — | $603.2M |
| Q4 25 | $-302.0M | $-392.1M | ||
| Q3 25 | $-451.4M | $-374.5M | ||
| Q2 25 | $-433.5M | $-347.8M | ||
| Q1 25 | $-426.2M | $-288.1M | ||
| Q4 24 | $-388.7M | $-202.1M | ||
| Q3 24 | $-370.2M | $-117.7M | ||
| Q2 24 | $-344.2M | $-72.2M | ||
| Q1 24 | $-294.3M | $936.0K |
| Q4 25 | $465.9M | $968.8M | ||
| Q3 25 | $364.0M | $973.0M | ||
| Q2 25 | $347.1M | $1.0B | ||
| Q1 25 | $324.0M | $1.1B | ||
| Q4 24 | $343.8M | $1.2B | ||
| Q3 24 | $314.1M | $1.0B | ||
| Q2 24 | $352.3M | $1.1B | ||
| Q1 24 | $373.1M | $1.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 644.43× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $-18.4M |
| Free Cash FlowOCF − Capex | — | $-58.3M |
| FCF MarginFCF / Revenue | — | -31.7% |
| Capex IntensityCapex / Revenue | 0.0% | 21.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-259.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $-18.4M | ||
| Q3 25 | $-4.3M | $-37.1M | ||
| Q2 25 | $-31.4M | $-62.9M | ||
| Q1 25 | $-22.6M | $-47.9M | ||
| Q4 24 | $-35.0M | $37.9M | ||
| Q3 24 | $-35.3M | $-16.9M | ||
| Q2 24 | $-7.2M | $-25.2M | ||
| Q1 24 | $53.8M | $-73.8M |
| Q4 25 | — | $-58.3M | ||
| Q3 25 | — | $-60.4M | ||
| Q2 25 | — | $-78.6M | ||
| Q1 25 | — | $-62.6M | ||
| Q4 24 | — | $-70.2M | ||
| Q3 24 | $-35.5M | $-21.9M | ||
| Q2 24 | $-7.3M | $-30.8M | ||
| Q1 24 | $53.8M | $-77.8M |
| Q4 25 | — | -31.7% | ||
| Q3 25 | — | -32.6% | ||
| Q2 25 | — | -41.5% | ||
| Q1 25 | — | -35.3% | ||
| Q4 24 | — | -34.3% | ||
| Q3 24 | -68.7% | -11.3% | ||
| Q2 24 | -9.9% | -15.7% | ||
| Q1 24 | 39.0% | -39.5% |
| Q4 25 | 0.0% | 21.7% | ||
| Q3 25 | 0.0% | 12.5% | ||
| Q2 25 | 0.0% | 8.3% | ||
| Q1 25 | 0.0% | 8.3% | ||
| Q4 24 | 0.0% | 52.8% | ||
| Q3 24 | 0.3% | 2.6% | ||
| Q2 24 | 0.1% | 2.9% | ||
| Q1 24 | 0.1% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
UP
Segment breakdown not available.
